CXCR4-directed PET/CT in patients with newly diagnosed neuroendocrine carcinomas

A Weich, RA Werner, AK Buck, PE Hartrampf… - Diagnostics, 2021 - mdpi.com
tumor lesions to allow for an evaluation of CXCR4-directed ERT [13,14,15,16]. In the present
study, we examined the diagnostic potential of CXCR4-directed … F-FDG PET/CT. Additionally…

[PDF][PDF] CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics 2021, 11, 605

A Weich, RA Werner, AK Buck, PE Hartrampf… - 2021 - pdfs.semanticscholar.org
tumor lesions to allow for an evaluation of CXCR4-directed ERT [13–16]. In the present
study, we examined the diagnostic potential of CXCR4-directed … 18F-FDG PET/CT. Additionally, …

CXCR4-directed imaging in solid tumors

RA Werner, S Kircher, T Higuchi, M Kircher… - Frontiers in …, 2019 - frontiersin.org
… levels of tumor de-differentiation and predict lesions with prognostic relevance. For example,
CXCR4-directed PET/CT might help to visualize receptor positive cancer stem cells (and …

Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas

K Michalski, W Schlötelburg, P Hartrampf… - Molecular Imaging and …, 2024 - Springer
… -derived CXCR4-directed whole-body PET signal can also determine GEP-NEC patients with
… -naive patients, the diagnostic performance of CXCR4 PET/CT was inferior to those of FDG …

Impact of CXCR4-directed PET/CT on staging and proposed oncologic management in patients with digestive system tumors

A Weich, SE Serfling, W Schlötelburg… - Clinical nuclear …, 2023 - journals.lww.com
… database and identified 654 [ 68 Ga]Ga-pentixafor PET/CTpatients with solid digestive
tract cancers with available concurrent GAI. Patients were referred for a CXCR4-directed PET/CT

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology

N Dreher, S Hahner, CT Fuß, W Schlötelburg… - European Journal of …, 2024 - Springer
patients with 23 different kinds of solid cancerstumor burden, which then allowed to
sort tumor entities based on intensity of uptake. Regarding myeloablative effects of CXCR4-directed

CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms

D Sanchis-Pascual, MI Del Olmo-García… - Cancers, 2024 - mdpi.com
… increasing tumor grade, which influences the 68Ga-PET/CT … -Pentixafor PET/CT in 11 patients
newly diagnosed from GEP-… -patient analysis, 18F-FDG-avid lesions were detected in all …

[HTML][HTML] Imaging of chemokine receptor 4 expression in neuroendocrine tumors-a triple tracer comparative approach

RA Werner, A Weich, T Higuchi, JS Schmid… - Theranostics, 2017 - ncbi.nlm.nih.gov
CXCR4-directed PET was negative in all G1 NET. In contrast… % of G3 patients exhibited [ 68
Ga]Pentixafor-positive tumor … ) and fused PET/CT (middle) images of the primary tumor in the …

Imaging of CXC motif chemokine receptor 4 expression in 690 patients with solid or hematologic neoplasms using 68Ga-pentixafor PET

AK Buck, A Haug, N Dreher, A Lambertini… - Journal of Nuclear …, 2022 - Soc Nuclear Med
… cohort of patients imaged with 68 Ga-Pentixafor PET/CT or … and image contrast in several
cancers to determine the most … of patients may also be eligible for CXCR4-directed radioligand …

CXCR4-targeted theranostics in oncology

AK Buck, SE Serfling, T Lindner, H Hänscheid… - European Journal of …, 2022 - Springer
patients affected with advanced blood cancer. In the present review, we will provide an overview
of CXCR4-directed molecular imaging for solid tumorsPET/CT also showed radiotracer …